Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie

New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences - The Globe and Mail

The Globe and Mail

Bright Minds Biosciences Announces Upcoming AGM - TipRanks.com - TipRanks

TipRanks

Bright Minds Biosciences Reports Financial Downturn - TipRanks.com - TipRanks

TipRanks

Mind Medicine sends psychedelic stocks higher on LSD drug - Seeking Alpha

Seeking Alpha

Bright Minds trims losses, but deficit grows - Green Market Report

Green Market Report

Short sales on the TSX: What bearish investors are betting against - The Globe and Mail

The Globe and Mail

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More - Benzinga

Benzinga

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More - Com - Benzinga

Benzinga

PurMinds Appoints Leading Drug Designer to Scientific Advisory Board - Microdose Psychedelic Insights

Microdose Psychedelic Insights

Serotonin agonist BMB-101 found safe, well-tolerated in healthy... - Dravet Syndrome News

Dravet Syndrome News

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More - Markets Insider

Markets Insider

Bright Minds completes first-in-human study of BMB-101 - Clinical Trials Arena

Clinical Trials Arena

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound ... - GlobeNewswire

GlobeNewswire

Bright Minds Announces Effective Date of Share Consolidation - Yahoo Finance

Yahoo Finance

Bright Minds Announces Proposed Share Consolidation - GlobeNewswire

GlobeNewswire

Perfect time to invest in psychedelics before Big Pharma makes its move: VC fund manager - Proactive Investors USA

Proactive Investors USA

Psychedelics Stocks to Watch - Investing News Network

Investing News Network

Who's Suing Whom: April 19, 2023 - Business in Vancouver

Business in Vancouver

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research - Psychedelic Alpha

Psychedelic Alpha

Bright Minds' Dravet syndrome treatment shows promise in trial |... - Dravet Syndrome News

Dravet Syndrome News

PsychedelicScape 2023: Psychedelic Companies Building the Future - NuWire Investor

NuWire Investor

Most Funded Psychedelic Companies 2023 - NuWire Investor

NuWire Investor

Post-traumatic Stress Disorder Clinical Trials Pipeline Analysis: 25+ Companies are Working to Improve the Treatment ... - GlobeNewswire

GlobeNewswire

Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket By Benzinga - Investing.com UK

Investing.com UK

Dow, S&P 500 Edge Lower Following Powell's Comments - Markets Insider

Markets Insider

Psychedelic Drug Therapy May Help Treat Alcohol Addiction - NYU Langone Health

NYU Langone Health

Psychedelic Therapeutics Market worth $ 8.31 billion by 2028 - Exclusive Report by InsightAce Analytic - PR Newswire

PR Newswire

BioSpace Movers & Shakers: Evommune, Maravai, Aptose & More - BioSpace

BioSpace

Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type ... - GlobalData

GlobalData

Psychedelic Sector Overview - Psychedelic Alpha

Psychedelic Alpha

Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type ... - GlobalData

GlobalData

Psychedelic Therapy and Suicide: A Myth Busted? - Medscape

Medscape

Bright Minds Biosciences to Present at the H.C. Wainwright Bioconnect Conference - Yahoo Finance

Yahoo Finance

Bright Minds Biosciences (DRUG) Stock Price, News & Analysis - MarketBeat

MarketBeat

Investing in Shroom Stocks | Psilocybin Stock Picks - Value the Markets

Value the Markets

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker Symbol “DRUG” - GlobeNewswire

GlobeNewswire

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug ... - Yahoo Finance

Yahoo Finance

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are - Compass Pathways (NASDAQ:CMP - Benzinga

Benzinga

Interview with Bright Minds Biosciences' CEO Ian McDonald - Psychedelic Spotlight

Psychedelic Spotlight

Interview with Ian McDonald, CEO & Director of Bright Minds Biosciences - Psychedelic Spotlight

Psychedelic Spotlight

Sandoz Share Price | RNS News, Quotes, & Charts | | - Proactive Investors USA

Proactive Investors USA

List of Top Psychedelics Startups That Raised the Most Funding in 2020 - Business Insider

Business Insider

Cannabis Movers & Shakers: Kathleen Sebelius Joins NCR, BDSA Names New Chair, Next Frontier Has A New CEO - Benzinga

Benzinga

Saga Communications Stock (NASDAQ:SGA), Quotes and News Summary - Benzinga

Benzinga

Have a good trip: Psychedelic drug developers all set for take-off - BioWorld Online

BioWorld Online